Arrowhead CEO provides perspective on $4.5 million alliance between subsidiary Unidym and Samsung ElectronicsDecember 10, 2010 8:34 am | by I-Micronews | News | Comments
Arrowhead Research Corporation's President and Chief Executive Officer today issued the following open letter to the Company's shareholders:
ItN Nanovation AG, a portfolio company of Nanostart AG, has announced the signing of a conditional equity investment agreement of up to EUR 15 million with YA Global Master SPV Ltd., which is managed by Yorkville Advisors, LLC, a large U.S.-based investment group.
Despite their initial focus on national economic competitiveness, the nanotechnology research initiatives now funded by more than 60 countries have become increasingly collaborative, with nearly a quarter of all papers co-authored by researchers across borders.
SAN ANTONIO - For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
European Commissioner Neelie Kroes will make a keynote address at the annual meeting of the Photonics21 European Technology Platform.
Innovative Micro Technology, Inc. (IMT) announced today the addition of a new geometry point in its technology roadmap for Through Silicon Vias (TSVs).
Taiwan Semiconductor Manufacturing Co Ltd (TSMC) had a lecture on its efforts to mass-produce 3D chips made by three-dimensionally stacking semiconductor chips by using its TSV (through silicon via) technology.
Ms. Febus-Sampayo discusses the cultural challenges faced by Latina women when they receive a cancer diagnosis, shares advice about how clinicians can best serve the Latina women who have cancer, and the long-term goals of her organization.
WASHINGTON, Dec. 10, 2010 /PRNewswire-USNewswire/ -- Voters would rather reduce Medicaid spending by better managing pharmacy benefits rather than cutting benefits for patients or payments to doctors and hospitals, according to a new poll commissioned by the Pharmaceutical Care Management...
WESTPORT, Conn., Dec. 10, 2010 /- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine , today announced the appointment of Kevin C. O'Boyle, as Senior Vice President and Chief Financial Officer. (Photo:...
AUSTIN, Texas, Dec. 10, 2010 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced today the pricing of the previously announced public offering of 2,000,000 shares of its common stock by Ares Corporate Opportunities Fund, L.P. at a public offering price of $20.00 per share. The...
Dr. Arteaga discusses targeted drugs for breast cancer, endocrine resistance, clinical trial enrollment criteria and his reactions to some of the important presentations at this year's symposium.
Dr. Dang discusses the major points of his plenary session, â€œOncogenic Reprogramming of Metabolism and Therapy,â€ including how oncogenic alterations in cancers lead to altered tumor metabolism, and the function of the c-myc oncoprotein, which has emerged as a central oncogenic switch in...
Dr. Moulder talks about her research on PARP inhibitors for hard-to-treat breast cancers, such as triple-negative breast cancer, and the collaborative team that continues this line of research.
Dr. Sledge talks about the results of the first large nationwide study on the use of Taxol for advanced breast cancer, his perspective on new therapies for breast cancer, and his goals as president of the American Society of Clinical Oncology.